Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
32
KURE Quote, Financials, Valuation and Earnings
Last price:
$14.45
Seasonality move
:
-3.78%
Day range:
$14.31 - $14.46
52-week range:
$12.91 - $20.51
Dividend yield:
1.27%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
6K
Avg. volume:
14K
1-year change:
-14.11%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
KURE
KraneShares MSCI All China Health Care Index ETF
|
-- | -- | -- | -- | -- |
|
CXSE
WisdomTree China ex-State-Owned Enterprises Fund
|
-- | -- | -- | -- | -- |
|
GXC
SPDR S&P China ETF
|
-- | -- | -- | -- | -- |
|
KGRN
KraneShares MSCI China Clean Technology Index ETF
|
-- | -- | -- | -- | -- |
|
MCHI
iShares MSCI China ETF
|
-- | -- | -- | -- | -- |
|
PGJ
Invesco Golden Dragon China ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
KURE
KraneShares MSCI All China Health Care Index ETF
|
$14.43 | -- | -- | -- | $0.18 | 1.27% | -- |
|
CXSE
WisdomTree China ex-State-Owned Enterprises Fund
|
$30.40 | -- | -- | -- | $0.14 | 1.79% | -- |
|
GXC
SPDR S&P China ETF
|
$77.89 | -- | -- | -- | $0.63 | 2.97% | -- |
|
KGRN
KraneShares MSCI China Clean Technology Index ETF
|
$22.61 | -- | -- | -- | $0.33 | 1.48% | -- |
|
MCHI
iShares MSCI China ETF
|
$47.10 | -- | -- | -- | $0.89 | 2.3% | -- |
|
PGJ
Invesco Golden Dragon China ETF
|
$26.44 | -- | -- | -- | $0.15 | 5.9% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
KURE
KraneShares MSCI All China Health Care Index ETF
|
-- | 1.328 | -- | -- |
|
CXSE
WisdomTree China ex-State-Owned Enterprises Fund
|
-- | 1.276 | -- | -- |
|
GXC
SPDR S&P China ETF
|
-- | 1.002 | -- | -- |
|
KGRN
KraneShares MSCI China Clean Technology Index ETF
|
-- | 1.726 | -- | -- |
|
MCHI
iShares MSCI China ETF
|
-- | 0.993 | -- | -- |
|
PGJ
Invesco Golden Dragon China ETF
|
-- | 1.607 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
KURE
KraneShares MSCI All China Health Care Index ETF
|
-- | -- | -- | -- | -- | -- |
|
CXSE
WisdomTree China ex-State-Owned Enterprises Fund
|
-- | -- | -- | -- | -- | -- |
|
GXC
SPDR S&P China ETF
|
-- | -- | -- | -- | -- | -- |
|
KGRN
KraneShares MSCI China Clean Technology Index ETF
|
-- | -- | -- | -- | -- | -- |
|
MCHI
iShares MSCI China ETF
|
-- | -- | -- | -- | -- | -- |
|
PGJ
Invesco Golden Dragon China ETF
|
-- | -- | -- | -- | -- | -- |
KraneShares MSCI All China Health Care Index ETF vs. Competitors
-
Which has Higher Returns KURE or CXSE?
WisdomTree China ex-State-Owned Enterprises Fund has a net margin of -- compared to KraneShares MSCI All China Health Care Index ETF's net margin of --. KraneShares MSCI All China Health Care Index ETF's return on equity of -- beat WisdomTree China ex-State-Owned Enterprises Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital KUREKraneShares MSCI All China Health Care Index ETF-- -- -- CXSEWisdomTree China ex-State-Owned Enterprises Fund-- -- -- -
What do Analysts Say About KURE or CXSE?
KraneShares MSCI All China Health Care Index ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand WisdomTree China ex-State-Owned Enterprises Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that KraneShares MSCI All China Health Care Index ETF has higher upside potential than WisdomTree China ex-State-Owned Enterprises Fund, analysts believe KraneShares MSCI All China Health Care Index ETF is more attractive than WisdomTree China ex-State-Owned Enterprises Fund.
Company Buy Ratings Hold Ratings Sell Ratings KUREKraneShares MSCI All China Health Care Index ETF0 0 0 CXSEWisdomTree China ex-State-Owned Enterprises Fund0 0 0 -
Is KURE or CXSE More Risky?
KraneShares MSCI All China Health Care Index ETF has a beta of 0.580, which suggesting that the stock is 41.991% less volatile than S&P 500. In comparison WisdomTree China ex-State-Owned Enterprises Fund has a beta of 0.867, suggesting its less volatile than the S&P 500 by 13.322%.
-
Which is a Better Dividend Stock KURE or CXSE?
KraneShares MSCI All China Health Care Index ETF has a quarterly dividend of $0.18 per share corresponding to a yield of 1.27%. WisdomTree China ex-State-Owned Enterprises Fund offers a yield of 1.79% to investors and pays a quarterly dividend of $0.14 per share. KraneShares MSCI All China Health Care Index ETF pays -- of its earnings as a dividend. WisdomTree China ex-State-Owned Enterprises Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios KURE or CXSE?
KraneShares MSCI All China Health Care Index ETF quarterly revenues are --, which are smaller than WisdomTree China ex-State-Owned Enterprises Fund quarterly revenues of --. KraneShares MSCI All China Health Care Index ETF's net income of -- is lower than WisdomTree China ex-State-Owned Enterprises Fund's net income of --. Notably, KraneShares MSCI All China Health Care Index ETF's price-to-earnings ratio is -- while WisdomTree China ex-State-Owned Enterprises Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KraneShares MSCI All China Health Care Index ETF is -- versus -- for WisdomTree China ex-State-Owned Enterprises Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income KUREKraneShares MSCI All China Health Care Index ETF-- -- -- -- CXSEWisdomTree China ex-State-Owned Enterprises Fund-- -- -- --
-
Which has Higher Returns KURE or GXC?
SPDR S&P China ETF has a net margin of -- compared to KraneShares MSCI All China Health Care Index ETF's net margin of --. KraneShares MSCI All China Health Care Index ETF's return on equity of -- beat SPDR S&P China ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital KUREKraneShares MSCI All China Health Care Index ETF-- -- -- GXCSPDR S&P China ETF-- -- -- -
What do Analysts Say About KURE or GXC?
KraneShares MSCI All China Health Care Index ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P China ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that KraneShares MSCI All China Health Care Index ETF has higher upside potential than SPDR S&P China ETF, analysts believe KraneShares MSCI All China Health Care Index ETF is more attractive than SPDR S&P China ETF.
Company Buy Ratings Hold Ratings Sell Ratings KUREKraneShares MSCI All China Health Care Index ETF0 0 0 GXCSPDR S&P China ETF0 0 0 -
Is KURE or GXC More Risky?
KraneShares MSCI All China Health Care Index ETF has a beta of 0.580, which suggesting that the stock is 41.991% less volatile than S&P 500. In comparison SPDR S&P China ETF has a beta of 0.802, suggesting its less volatile than the S&P 500 by 19.751%.
-
Which is a Better Dividend Stock KURE or GXC?
KraneShares MSCI All China Health Care Index ETF has a quarterly dividend of $0.18 per share corresponding to a yield of 1.27%. SPDR S&P China ETF offers a yield of 2.97% to investors and pays a quarterly dividend of $0.63 per share. KraneShares MSCI All China Health Care Index ETF pays -- of its earnings as a dividend. SPDR S&P China ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios KURE or GXC?
KraneShares MSCI All China Health Care Index ETF quarterly revenues are --, which are smaller than SPDR S&P China ETF quarterly revenues of --. KraneShares MSCI All China Health Care Index ETF's net income of -- is lower than SPDR S&P China ETF's net income of --. Notably, KraneShares MSCI All China Health Care Index ETF's price-to-earnings ratio is -- while SPDR S&P China ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KraneShares MSCI All China Health Care Index ETF is -- versus -- for SPDR S&P China ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income KUREKraneShares MSCI All China Health Care Index ETF-- -- -- -- GXCSPDR S&P China ETF-- -- -- --
-
Which has Higher Returns KURE or KGRN?
KraneShares MSCI China Clean Technology Index ETF has a net margin of -- compared to KraneShares MSCI All China Health Care Index ETF's net margin of --. KraneShares MSCI All China Health Care Index ETF's return on equity of -- beat KraneShares MSCI China Clean Technology Index ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital KUREKraneShares MSCI All China Health Care Index ETF-- -- -- KGRNKraneShares MSCI China Clean Technology Index ETF-- -- -- -
What do Analysts Say About KURE or KGRN?
KraneShares MSCI All China Health Care Index ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand KraneShares MSCI China Clean Technology Index ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that KraneShares MSCI All China Health Care Index ETF has higher upside potential than KraneShares MSCI China Clean Technology Index ETF, analysts believe KraneShares MSCI All China Health Care Index ETF is more attractive than KraneShares MSCI China Clean Technology Index ETF.
Company Buy Ratings Hold Ratings Sell Ratings KUREKraneShares MSCI All China Health Care Index ETF0 0 0 KGRNKraneShares MSCI China Clean Technology Index ETF0 0 0 -
Is KURE or KGRN More Risky?
KraneShares MSCI All China Health Care Index ETF has a beta of 0.580, which suggesting that the stock is 41.991% less volatile than S&P 500. In comparison KraneShares MSCI China Clean Technology Index ETF has a beta of 1.031, suggesting its more volatile than the S&P 500 by 3.094%.
-
Which is a Better Dividend Stock KURE or KGRN?
KraneShares MSCI All China Health Care Index ETF has a quarterly dividend of $0.18 per share corresponding to a yield of 1.27%. KraneShares MSCI China Clean Technology Index ETF offers a yield of 1.48% to investors and pays a quarterly dividend of $0.33 per share. KraneShares MSCI All China Health Care Index ETF pays -- of its earnings as a dividend. KraneShares MSCI China Clean Technology Index ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios KURE or KGRN?
KraneShares MSCI All China Health Care Index ETF quarterly revenues are --, which are smaller than KraneShares MSCI China Clean Technology Index ETF quarterly revenues of --. KraneShares MSCI All China Health Care Index ETF's net income of -- is lower than KraneShares MSCI China Clean Technology Index ETF's net income of --. Notably, KraneShares MSCI All China Health Care Index ETF's price-to-earnings ratio is -- while KraneShares MSCI China Clean Technology Index ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KraneShares MSCI All China Health Care Index ETF is -- versus -- for KraneShares MSCI China Clean Technology Index ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income KUREKraneShares MSCI All China Health Care Index ETF-- -- -- -- KGRNKraneShares MSCI China Clean Technology Index ETF-- -- -- --
-
Which has Higher Returns KURE or MCHI?
iShares MSCI China ETF has a net margin of -- compared to KraneShares MSCI All China Health Care Index ETF's net margin of --. KraneShares MSCI All China Health Care Index ETF's return on equity of -- beat iShares MSCI China ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital KUREKraneShares MSCI All China Health Care Index ETF-- -- -- MCHIiShares MSCI China ETF-- -- -- -
What do Analysts Say About KURE or MCHI?
KraneShares MSCI All China Health Care Index ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares MSCI China ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that KraneShares MSCI All China Health Care Index ETF has higher upside potential than iShares MSCI China ETF, analysts believe KraneShares MSCI All China Health Care Index ETF is more attractive than iShares MSCI China ETF.
Company Buy Ratings Hold Ratings Sell Ratings KUREKraneShares MSCI All China Health Care Index ETF0 0 0 MCHIiShares MSCI China ETF0 0 0 -
Is KURE or MCHI More Risky?
KraneShares MSCI All China Health Care Index ETF has a beta of 0.580, which suggesting that the stock is 41.991% less volatile than S&P 500. In comparison iShares MSCI China ETF has a beta of 0.820, suggesting its less volatile than the S&P 500 by 18.019%.
-
Which is a Better Dividend Stock KURE or MCHI?
KraneShares MSCI All China Health Care Index ETF has a quarterly dividend of $0.18 per share corresponding to a yield of 1.27%. iShares MSCI China ETF offers a yield of 2.3% to investors and pays a quarterly dividend of $0.89 per share. KraneShares MSCI All China Health Care Index ETF pays -- of its earnings as a dividend. iShares MSCI China ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios KURE or MCHI?
KraneShares MSCI All China Health Care Index ETF quarterly revenues are --, which are smaller than iShares MSCI China ETF quarterly revenues of --. KraneShares MSCI All China Health Care Index ETF's net income of -- is lower than iShares MSCI China ETF's net income of --. Notably, KraneShares MSCI All China Health Care Index ETF's price-to-earnings ratio is -- while iShares MSCI China ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KraneShares MSCI All China Health Care Index ETF is -- versus -- for iShares MSCI China ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income KUREKraneShares MSCI All China Health Care Index ETF-- -- -- -- MCHIiShares MSCI China ETF-- -- -- --
-
Which has Higher Returns KURE or PGJ?
Invesco Golden Dragon China ETF has a net margin of -- compared to KraneShares MSCI All China Health Care Index ETF's net margin of --. KraneShares MSCI All China Health Care Index ETF's return on equity of -- beat Invesco Golden Dragon China ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital KUREKraneShares MSCI All China Health Care Index ETF-- -- -- PGJInvesco Golden Dragon China ETF-- -- -- -
What do Analysts Say About KURE or PGJ?
KraneShares MSCI All China Health Care Index ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Golden Dragon China ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that KraneShares MSCI All China Health Care Index ETF has higher upside potential than Invesco Golden Dragon China ETF, analysts believe KraneShares MSCI All China Health Care Index ETF is more attractive than Invesco Golden Dragon China ETF.
Company Buy Ratings Hold Ratings Sell Ratings KUREKraneShares MSCI All China Health Care Index ETF0 0 0 PGJInvesco Golden Dragon China ETF0 0 0 -
Is KURE or PGJ More Risky?
KraneShares MSCI All China Health Care Index ETF has a beta of 0.580, which suggesting that the stock is 41.991% less volatile than S&P 500. In comparison Invesco Golden Dragon China ETF has a beta of 1.061, suggesting its more volatile than the S&P 500 by 6.144%.
-
Which is a Better Dividend Stock KURE or PGJ?
KraneShares MSCI All China Health Care Index ETF has a quarterly dividend of $0.18 per share corresponding to a yield of 1.27%. Invesco Golden Dragon China ETF offers a yield of 5.9% to investors and pays a quarterly dividend of $0.15 per share. KraneShares MSCI All China Health Care Index ETF pays -- of its earnings as a dividend. Invesco Golden Dragon China ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios KURE or PGJ?
KraneShares MSCI All China Health Care Index ETF quarterly revenues are --, which are smaller than Invesco Golden Dragon China ETF quarterly revenues of --. KraneShares MSCI All China Health Care Index ETF's net income of -- is lower than Invesco Golden Dragon China ETF's net income of --. Notably, KraneShares MSCI All China Health Care Index ETF's price-to-earnings ratio is -- while Invesco Golden Dragon China ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KraneShares MSCI All China Health Care Index ETF is -- versus -- for Invesco Golden Dragon China ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income KUREKraneShares MSCI All China Health Care Index ETF-- -- -- -- PGJInvesco Golden Dragon China ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
